Neural Mechanisms of Emotion-behaviour Interactions
EMOBB
Neural and Cognitive Mechanism of Adaptive and Maladaptive Interplay Between Emotions in Behaviour in Naturalistic Tasks
2 other identifiers
interventional
120
1 country
1
Brief Summary
Deciding what to do when for how long - self-organizing one's behaviour - is an important feature of daily life. Emotions arise providing short-cuts for the computational complexities. Yet, one still knows relatively little about the underlying cognitive and neural mechanisms. EMOBB will establish the computational, cognitive and neural underpinnings of the rich interplay between emotions and self-organized behaviour in naturalistic environments. Previous work has almost exclusively relied on tasks structured into experimenter determined trials - thus how people self-organized behaviour could not be measured. To overcome this, EMOBB will combine novel naturalistic tasks in which people have freedom what to do when for how long with subjective and objective measurements of emotions. This will be made possible through a computational modelling approach that allows dissecting and quantifying even complex behaviour-emotion interactions. Specifically, EMOBB will use three cognitive tasks of emotion-behaviour interplay that participants will do while undergoing functional magnetic resonance brain imaging and monitoring of their facial expressions with an MRI-compatible camera. The primary hypothesis of EMOBB is that both unique and shared neural networks will underpin the interplay between emotions and behaviour across our cognitive tasks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2030
Study Completion
Last participant's last visit for all outcomes
October 10, 2030
June 3, 2026
May 1, 2026
4 years
May 20, 2026
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain activity in regions of interest
Brain activity is captured as percentage change in blood-oxygen-level-dependent (BOLD) signal with FMRI compared to baseline across tasks across brain regions (ventromedial prefrontal cortex, vmPFC; dorsal anterior cingulate cortex, dACC).
Day 0
Secondary Outcomes (3)
Brain activity during task 1 (Self-organization under threat)
Day 0
Brain activity during task 2 (Self-organization and learning)
Day 0
Brain activity during task 3 (Self-organization and social context)
Day 0
Study Arms (3)
Task 1: self-organization under threat
EXPERIMENTALTask 2: self-organization and learning
EXPERIMENTALTask 3 : self-organization and social context
EXPERIMENTALInterventions
Participants will perform a cognitive task (responses through button presses) while we measure brain activity with functional magnetic resonance imaging (fMRI) and record their facial expressions.
Eligibility Criteria
You may qualify if:
- years old,
- fluent French speakers,
- healthy,
- without a beard at the time of testing,
- right-handed,
- being able to use both hands
- BMI between 18.5 and 30
- give written informed consen
- for women: contraception;
You may not qualify if:
- neurological, psychiatric disorders, or severe chronic disorders (diabetes, cardiac, kidney, lung, liver disorders, inflammatory disorders)
- pregnancy or breast-feeding
- under guardianship, currently admitted to a psychiatric hospital other than for research purposes)
- not wanting to be informed of abnormalities detected during MRI scan,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CERMEP (Centre d'Etude de Recherche Multimodal et pluridisciplinaire en imagerie du vivant)
Bron, 69500, France
Study Officials
- PRINCIPAL INVESTIGATOR
Jacqueline SCHOLL, PhD
Institut National de la Santé Et de la Recherche Médicale, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2026
First Posted
June 3, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
October 1, 2030
Study Completion (Estimated)
October 10, 2030
Last Updated
June 3, 2026
Record last verified: 2026-05